Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Pancreatic cancer	4/76	1.4558243895816926e-06	8.00703414269931e-05	74.03703703703704	-172.05130589538587	SMAD4;TGFB1;TGFBR1;VEGFA
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	4/100	4.3860489555289296e-06	0.00012061634627704557	55.361111111111114	-136.84140632930726	SMAD4;TGFB1;TGFBR1;VEGFA
KEGG_2021_Human	Chronic myeloid leukemia	3/76	9.159620399517935e-05	0.0016792637399116214	46.93737769080235	-88.55605413655218	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Colorectal cancer	3/86	0.0001324740846980751	0.0018215186645985327	41.230636833046475	-79.65388581050792	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	TGF-beta signaling pathway	3/94	0.00017260861398757182	0.00189869475386329	37.56828885400314	-73.71479219141467	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Th17 cell differentiation	3/107	0.0002534260244380865	0.0023230718906824595	32.81868131868132	-65.71442008901244	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Cytokine-cytokine receptor interaction	4/295	0.0003074189702429336	0.0024154347661944782	17.81672394043528	-49.58458596249444	ACVRL1;GDF2;TGFB1;TGFBR1
KEGG_2021_Human	Relaxin signaling pathway	3/129	0.00043986806704120836	0.002812384689622802	27.01360544217687	-55.40965280021221	TGFB1;TGFBR1;VEGFA
KEGG_2021_Human	FoxO signaling pathway	3/131	0.0004602084037564585	0.002812384689622802	26.584821428571427	-54.62268457986884	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Gastric cancer	3/149	0.0006711090600743852	0.0036910998304091184	23.25440313111546	-48.37496566440217	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Hippo signaling pathway	3/163	0.0008721049172913414	0.003997147537585315	21.182142857142857	-44.35724000081694	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Hepatitis B	3/162	0.000856615716023289	0.003997147537585315	21.318059299191376	-44.62403509135876	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Hepatocellular carcinoma	3/168	0.0009522461559574535	0.004028733736743072	20.527272727272727	-43.06507884394289	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Malaria	2/50	0.0016370061401984127	0.006431095550779479	41.770833333333336	-50.1560330081587	PECAM1;TGFB1
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	3/219	0.0020484263518845244	0.00751089662357659	15.579365079365079	-32.91284230349772	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Pathways in cancer	4/531	0.0028173482711087343	0.009684634681936274	9.539531941808981	-25.060320343159585	SMAD4;TGFB1;TGFBR1;VEGFA
KEGG_2021_Human	Adherens junction	2/71	0.0032750085301139972	0.010006970508681658	28.981884057971016	-37.08506032826052	SMAD4;TGFBR1
KEGG_2021_Human	Renal cell carcinoma	2/69	0.0030959091544989293	0.010006970508681658	29.854477611940297	-38.032897794694755	TGFB1;VEGFA
KEGG_2021_Human	MAPK signaling pathway	3/294	0.0047334851717591615	0.013702193918250205	11.45360824742268	-23.841254126382374	TGFB1;TGFBR1;VEGFA
KEGG_2021_Human	Rheumatoid arthritis	2/93	0.005556617161068888	0.015280697192939442	21.914835164835164	-29.03004575134454	TGFB1;VEGFA
KEGG_2021_Human	Chagas disease	2/102	0.006650847322673755	0.01741888584509793	19.92	-26.61700675496218	TGFB1;TGFBR1
KEGG_2021_Human	Cell cycle	2/124	0.009704304916610982	0.024260762291527453	16.2827868852459	-22.027132854342252	SMAD4;TGFB1
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.024298819021382225	15.886	-21.510038502238015	TGFB1;TGFBR1
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.02658557680607904	14.472627737226277	-19.639406588988233	PECAM1;VEGFA
KEGG_2021_Human	Apelin signaling pathway	2/137	0.011753397776716717	0.02658557680607904	14.690740740740742	-19.931093924152265	SMAD4;TGFBR1
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.031863402487727406	12.847402597402597	-17.429441058365175	TGFB1;TGFBR1
KEGG_2021_Human	Diabetic cardiomyopathy	2/203	0.024762333575826773	0.04954025263892852	9.784825870646767	-13.073912909097736	TGFB1;TGFBR1
KEGG_2021_Human	Proteoglycans in cancer	2/205	0.025220492252545426	0.04954025263892852	9.685960591133005	-12.928804077098514	TGFB1;VEGFA
KEGG_2021_Human	Bladder cancer	1/41	0.04963848036556211	0.09414194552089367	22.3	-12.692261742471414	VEGFA
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.10612817577668385	18.962174940898347	-11.032973182262484	TGFB1
KEGG_2021_Human	VEGF signaling pathway	1/59	0.07072162222736704	0.12547384588726412	15.344827586206897	-9.124402207995153	VEGFA
KEGG_2021_Human	Inflammatory bowel disease	1/65	0.07765521083230079	0.13346989361801698	13.895833333333334	-8.322075559905016	TGFB1
KEGG_2021_Human	Leishmaniasis	1/77	0.09138288226635771	0.15230480377726285	11.68421052631579	-7.04872976578505	TGFB1
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.17154625882699695	9.961298377028713	-6.010407578745034	TGFB1
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.17716695666437443	9.32514619883041	-5.615549699272252	TGFB1
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.1824063818543011	8.764576457645765	-5.262086311101535	TGFB1
KEGG_2021_Human	Leukocyte transendothelial migration	1/114	0.13256015588280526	0.1869438095783151	7.822025565388397	-4.655477238055189	PECAM1
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.1869438095783151	7.964964964964965	-4.748494648054986	TGFB1
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.1869438095783151	8.189300411522634	-4.893732148578802	VEGFA
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	1/143	0.163651680714637	0.2250210609826259	6.2018779342723	-3.57415842622014	SMAD4
KEGG_2021_Human	Cell adhesion molecules	1/148	0.16890973234869874	0.22658622632142514	5.987150415721844	-3.427000500776257	PECAM1
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.2307656275873456	5.70995670995671	-3.235678410841787	TGFB1
KEGG_2021_Human	Wnt signaling pathway	1/166	0.1875932968535885	0.23994491458017134	5.321885521885521	-2.9652743858654524	SMAD4
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.2523283365858579	4.896958410924891	-2.6658400097237527	TGFB1
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	1/193	0.21491040066934372	0.2626682674847534	4.55787037037037	-2.4244944960200487	VEGFA
KEGG_2021_Human	Focal adhesion	1/201	0.22284403856827387	0.2664439591577188	4.371111111111111	-2.2907190203417165	VEGFA
KEGG_2021_Human	Rap1 signaling pathway	1/210	0.23168307497366095	0.2711184919904543	4.178096757044125	-2.1518791496475385	VEGFA
KEGG_2021_Human	Ras signaling pathway	1/232	0.25290994493508406	0.28092809276141695	3.7696007696007694	-1.8563524399324505	VEGFA
KEGG_2021_Human	Human cytomegalovirus infection	1/225	0.24621391857748554	0.28092809276141695	3.890873015873016	-1.9442968935376908	VEGFA
KEGG_2021_Human	Chemical carcinogenesis	1/239	0.2595523897792453	0.28092809276141695	3.6554621848739495	-1.7734497985532327	VEGFA
KEGG_2021_Human	Calcium signaling pathway	1/240	0.2604969587424048	0.28092809276141695	3.6397024639702464	-1.7619943041292825	VEGFA
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.2874252437533126	3.4603806994245243	-1.6315316807371463	TGFBR1
KEGG_2021_Human	MicroRNAs in cancer	1/310	0.3239838755949599	0.3362096822211848	2.7900035958288387	-1.143955577607994	VEGFA
KEGG_2021_Human	Human papillomavirus infection	1/331	0.3420488957114324	0.34838313452090336	2.6053872053872054	-1.0106876845884132	VEGFA
KEGG_2021_Human	PI3K-Akt signaling pathway	1/354	0.36133488698431165	0.36133488698431165	2.4283915643689014	-0.883914601009246	VEGFA
